COR vs PATH
Cencora Inc. (COR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
COR currently screens at market cap $53.91B and trailing P/E 21.2. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the COR and PATH stock pages for the full models.
Not investment advice.